XRAY Quote, Financials, Valuation and Earnings

Milestone Scientific, Inc. has a net margin of -47.35% compared to Dentsply Sirona, Inc.'s net margin of -48.9%. Dentsply Sirona, Inc.'s return on equity of -44.58% beat Milestone Scientific, Inc.'s return on equity of -142.42%.

Dentsply Sirona, Inc. has a consensus price target of $12.96, signalling upside risk potential of 14.37%. On the other hand Milestone Scientific, Inc. has an analysts' consensus of $1.00 which suggests that it could grow by 190.44%. Given that Milestone Scientific, Inc. has higher upside potential than Dentsply Sirona, Inc., analysts believe Milestone Scientific, Inc. is more attractive than Dentsply Sirona, Inc..

Dentsply Sirona, Inc. has a beta of 1.008, which suggesting that the stock is 0.82100000000001% more volatile than S&P 500. In comparison Milestone Scientific, Inc. has a beta of 0.937, suggesting its less volatile than the S&P 500 by 6.331%.

Dentsply Sirona, Inc. has a quarterly dividend of $0.16 per share corresponding to a yield of 5.65%. Milestone Scientific, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Dentsply Sirona, Inc. pays 13.85% of its earnings as a dividend. Milestone Scientific, Inc. pays out -- of its earnings as a dividend. Dentsply Sirona, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Dentsply Sirona, Inc. quarterly revenues are $904M, which are larger than Milestone Scientific, Inc. quarterly revenues of $2.4M. Dentsply Sirona, Inc.'s net income of -$428M is lower than Milestone Scientific, Inc.'s net income of -$1.2M. Notably, Dentsply Sirona, Inc.'s price-to-earnings ratio is -- while Milestone Scientific, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Dentsply Sirona, Inc. is 0.62x versus 3.13x for Milestone Scientific, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Envista Holdings Corp. has a net margin of -47.35% compared to Dentsply Sirona, Inc.'s net margin of -4.52%. Dentsply Sirona, Inc.'s return on equity of -44.58% beat Envista Holdings Corp.'s return on equity of 0.5%.

Dentsply Sirona, Inc. has a consensus price target of $12.96, signalling upside risk potential of 14.37%. On the other hand Envista Holdings Corp. has an analysts' consensus of $22.00 which suggests that it could grow by 7.58%. Given that Dentsply Sirona, Inc. has higher upside potential than Envista Holdings Corp., analysts believe Dentsply Sirona, Inc. is more attractive than Envista Holdings Corp..

Dentsply Sirona, Inc. has a beta of 1.008, which suggesting that the stock is 0.82100000000001% more volatile than S&P 500. In comparison Envista Holdings Corp. has a beta of 1.025, suggesting its more volatile than the S&P 500 by 2.453%.

Dentsply Sirona, Inc. has a quarterly dividend of $0.16 per share corresponding to a yield of 5.65%. Envista Holdings Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Dentsply Sirona, Inc. pays 13.85% of its earnings as a dividend. Envista Holdings Corp. pays out -- of its earnings as a dividend. Dentsply Sirona, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Dentsply Sirona, Inc. quarterly revenues are $904M, which are larger than Envista Holdings Corp. quarterly revenues of $669.9M. Dentsply Sirona, Inc.'s net income of -$428M is lower than Envista Holdings Corp.'s net income of -$30.3M. Notably, Dentsply Sirona, Inc.'s price-to-earnings ratio is -- while Envista Holdings Corp.'s PE ratio is 244.62x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Dentsply Sirona, Inc. is 0.62x versus 1.33x for Envista Holdings Corp.. Usually stocks with elevated PS ratios are considered overvalued.

Phibro Animal Health Corp. has a net margin of -47.35% compared to Dentsply Sirona, Inc.'s net margin of 7.29%. Dentsply Sirona, Inc.'s return on equity of -44.58% beat Phibro Animal Health Corp.'s return on equity of 24.77%.

Dentsply Sirona, Inc. has a consensus price target of $12.96, signalling upside risk potential of 14.37%. On the other hand Phibro Animal Health Corp. has an analysts' consensus of $43.00 which suggests that it could grow by 3.89%. Given that Dentsply Sirona, Inc. has higher upside potential than Phibro Animal Health Corp., analysts believe Dentsply Sirona, Inc. is more attractive than Phibro Animal Health Corp..

Dentsply Sirona, Inc. has a beta of 1.008, which suggesting that the stock is 0.82100000000001% more volatile than S&P 500. In comparison Phibro Animal Health Corp. has a beta of 0.771, suggesting its less volatile than the S&P 500 by 22.868%.

Dentsply Sirona, Inc. has a quarterly dividend of $0.16 per share corresponding to a yield of 5.65%. Phibro Animal Health Corp. offers a yield of 1.16% to investors and pays a quarterly dividend of $0.12 per share. Dentsply Sirona, Inc. pays 13.85% of its earnings as a dividend. Phibro Animal Health Corp. pays out 40.46% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

Dentsply Sirona, Inc. quarterly revenues are $904M, which are larger than Phibro Animal Health Corp. quarterly revenues of $363.9M. Dentsply Sirona, Inc.'s net income of -$428M is lower than Phibro Animal Health Corp.'s net income of $26.5M. Notably, Dentsply Sirona, Inc.'s price-to-earnings ratio is -- while Phibro Animal Health Corp.'s PE ratio is 24.88x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Dentsply Sirona, Inc. is 0.62x versus 1.21x for Phibro Animal Health Corp.. Usually stocks with elevated PS ratios are considered overvalued.

Solventum Corp. has a net margin of -47.35% compared to Dentsply Sirona, Inc.'s net margin of 60.4%. Dentsply Sirona, Inc.'s return on equity of -44.58% beat Solventum Corp.'s return on equity of 42.2%.

Dentsply Sirona, Inc. has a consensus price target of $12.96, signalling upside risk potential of 14.37%. On the other hand Solventum Corp. has an analysts' consensus of $84.36 which suggests that it could fall by -1.04%. Given that Dentsply Sirona, Inc. has higher upside potential than Solventum Corp., analysts believe Dentsply Sirona, Inc. is more attractive than Solventum Corp..

Dentsply Sirona, Inc. has a beta of 1.008, which suggesting that the stock is 0.82100000000001% more volatile than S&P 500. In comparison Solventum Corp. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

Dentsply Sirona, Inc. has a quarterly dividend of $0.16 per share corresponding to a yield of 5.65%. Solventum Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Dentsply Sirona, Inc. pays 13.85% of its earnings as a dividend. Solventum Corp. pays out -- of its earnings as a dividend. Dentsply Sirona, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Dentsply Sirona, Inc. quarterly revenues are $904M, which are smaller than Solventum Corp. quarterly revenues of $2.1B. Dentsply Sirona, Inc.'s net income of -$428M is lower than Solventum Corp.'s net income of $1.3B. Notably, Dentsply Sirona, Inc.'s price-to-earnings ratio is -- while Solventum Corp.'s PE ratio is 9.81x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Dentsply Sirona, Inc. is 0.62x versus 1.77x for Solventum Corp.. Usually stocks with elevated PS ratios are considered overvalued.